Month: June 2025
Federal Circuit Narrows “Consisting Essentially Of” in Eye Therapies v. Slayback Pharma Patent Dispute
June 30, 2025
Eye Therapies, LLC v. Slayback Pharma, LLC Authored by: Jeremy J. Gustrowsky In a significant decision for patent claim interpretation, the Federal Circuit recently reversed a Patent Trial and Appeal Board (PTAB) ruling in Eye Therapies, LLC v. Slayback Pharma,…
Read MoreFederal Circuit Dismisses Realtek’s Appeal Over ITC Sanctions for Lack of Jurisdiction
June 18, 2025
Realtek Semiconductor Corp. v. Int’l Trade Comm’n Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit clarified the limits of its authority to review certain decisions made by the U.S. International Trade Commission (ITC). The case, Realtek…
Read MoreProtect Your Brand: Unlock the Power of Your Intellectual Property
June 18, 2025
As a business owner, it’s essential to recognize what makes your brand unique—this includes identifying your intellectual property (IP) assets. From words and logos to colors, sounds, and even packaging, anything that sets your products and services apart from the…
Read MoreFederal Circuit Vacates PTAB Ruling on Software Patent, Citing Flawed Review of Licensing Deals
June 16, 2025
Ancora Techs., Inc. v. Roku, Inc Authored by: Jeremy J. Gustrowsky In a recent decision, the U.S. Court of Appeals for the Federal Circuit stepped into a patent dispute over technology designed to protect licensed software from unauthorized copying on…
Read MoreApple Wins New Trial in $300 Million LTE Patent Dispute with Optis Over Jury Verdict Form and Damages Evidence
June 16, 2025
Optis Cellular Tech., LLC v. Apple Inc Authored by: Jeremy J. Gustrowsky In a significant decision for patent litigation, the Federal Circuit has vacated a $300 million damages award against Apple Inc. in its ongoing dispute with Optis Cellular Technology,…
Read MoreFederal Circuit Affirms Dismissal of Mitek’s Declaratory Judgment Suit Against USAA Over Mobile Banking Patents
June 12, 2025
Mitek Sys. v. United Servs. Auto. Ass’n Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit affirmed the dismissal of a declaratory judgment action brought by Mitek Systems, Inc. against United Services Automobile Association (USAA) regarding four…
Read MoreFederal Circuit Strikes Down USAA’s Mobile Check Deposit Patent as Ineligible Abstract Idea
June 12, 2025
United Servs. Auto. Ass’n v. PNC Bank N.A Authored by: Jeremy J. Gustrowsky In a significant decision for financial technology patents, the Federal Circuit reversed a lower court’s ruling and found that United Services Automobile Association’s (USAA) patent on mobile…
Read MoreFederal Circuit Affirms CRISPR Patent Invalidity in Gene Editing Dispute
June 11, 2025
Agilent Techs., Inc. v. Synthego Corp. Authored by: Jeremy J. Gustrowsky In a recent decision, the U.S. Court of Appeals for the Federal Circuit upheld a ruling that all claims in two patents owned by Agilent Technologies are unpatentable, dealing…
Read MorePatent Owner’s Silence Not Enough: Federal Circuit Revives Fraunhofer’s Patent Suit Against Sirius XM
June 9, 2025
Fraunhofer-Gesellschaft Zur F_rderung Der Angewandten Forschung E.V. v. Sirius XM Radio Inc Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit reversed a district court’s ruling that had blocked Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung E.V. from…
Read MoreWho Can Appeal a Patent Board Decision? Dolby Labs Learns the Limits
June 5, 2025
Dolby Labs. Licensing Corp. v. Unified Pats., LLC Authored by: Jeremy J. Gustrowsky The Federal Circuit recently dismissed an appeal by Dolby Laboratories Licensing Corporation, clarifying when a party can challenge a Patent Trial and Appeal Board (PTAB) decision in…
Read MorePatent Lexicography Takes Center Stage in Alnylam v. Moderna COVID-19 Vaccine Dispute
June 4, 2025
Alnylam Pharms., Inc. v. Moderna, Inc Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit affirmed a district court’s ruling in the high-profile patent dispute between Alnylam Pharmaceuticals, Inc. and Moderna, Inc. over Moderna’s COVID-19 vaccine, SPIKEVAX®.…
Read More